8-KThe WireRoutine
Reg FD Disclosure
Filed Dec 7, 2021 · 4y ago · Accession 0001558370-21-016573
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Dec 7, 2021
- Report date
- Dec 7, 2021
- Document
- acrs-20211207x8k.htm
- Size
- 12.8 MB